Pain Management for Acute Pericarditis
First-line therapy for acute pericarditis pain requires combination treatment with high-dose NSAIDs (aspirin 750-1000 mg every 8 hours OR ibuprofen 600 mg every 8 hours) PLUS colchicine (0.5 mg once daily if <70 kg or 0.5 mg twice daily if ≥70 kg), both with gastroprotection. 1
Treatment Algorithm
Initial Therapy (Class I, Level A Recommendations)
NSAIDs as Foundation:
- Aspirin: 750-1000 mg every 8 hours for 1-2 weeks 1
- Ibuprofen: 600 mg every 8 hours for 1-2 weeks 1
- Choose aspirin if patient already requires antiplatelet therapy for coronary disease 1
- Always provide gastroprotection (proton pump inhibitor) 1
Mandatory Addition of Colchicine:
- Weight-adjusted dosing: 0.5 mg once daily (<70 kg) or 0.5 mg twice daily (≥70 kg) 1
- Duration: 3 months minimum 1
- Critical benefit: Reduces recurrence from 37.5% to 16.7% (absolute risk reduction 20.8%) 2
- Colchicine halves the recurrence rate compared to NSAIDs alone 1
Monitoring and Tapering
Use C-reactive protein (CRP) to guide treatment:
- Continue full-dose NSAIDs until chest pain resolves AND CRP normalizes 1, 2
- Begin tapering NSAIDs only after symptom resolution and CRP normalization 1
- Aspirin taper: Decrease by 250-500 mg every 1-2 weeks 1
- Ibuprofen taper: Decrease by 200-400 mg every 1-2 weeks 1
- Colchicine tapering is not mandatory but can consider 0.5 mg every other day in final weeks 1
Second-Line Therapy (When First-Line Fails)
Corticosteroids are NOT first-line (Class III recommendation) 1 due to:
- Risk of promoting chronic disease evolution 1
- Increased recurrence rates (up to 50% after first recurrence) 1
- Drug dependence 1
Use low-dose corticosteroids ONLY if:
- Contraindications to NSAIDs (true allergy, recent GI bleeding, high bleeding risk on anticoagulation) 1
- Failure of adequate trial of NSAIDs plus colchicine 1
- Infectious cause definitively excluded 1
- Specific indication exists (autoimmune disease, pregnancy, post-pericardiotomy syndrome) 1
If corticosteroids required:
- Low-to-moderate dose: Prednisone 0.2-0.5 mg/kg/day (NOT 1.0 mg/kg/day) 1
- Add to NSAIDs and colchicine as triple therapy, don't replace them 1
- Maintain initial dose until symptom resolution and CRP normalization 1
- Very slow taper: Critical threshold is 10-15 mg/day prednisone—at this point decrease by only 1.0-2.5 mg every 2-6 weeks 1
Common Pitfalls to Avoid
Inadequate initial dosing: Sub-optimal adherence to guideline-recommended doses is common and associated with worse outcomes 3
Starting corticosteroids too early: This is the single biggest mistake—corticosteroids favor chronicity and recurrence 1
Omitting colchicine: 40% of patients don't receive colchicine on admission, though this improves to 71% at discharge 3—this drug is essential for preventing the 15-30% recurrence rate 1, 2
Rapid tapering: Tapering NSAIDs before CRP normalizes or tapering too quickly (especially corticosteroids) triggers recurrence 1
Increasing corticosteroid dose for breakthrough symptoms: Instead, maximize NSAIDs to full dose every 8 hours, add IV NSAIDs if needed, ensure colchicine is on board, and add analgesics for pain control 1
Exercise Restriction
- Non-athletes: Restrict exercise until symptom resolution and normalization of CRP, ECG, and echocardiogram 1
- Athletes: Minimum 3-month restriction after symptom onset, even after normalization of tests 1
High-Risk Features Requiring Admission
If symptoms don't respond to NSAIDs, admit for etiology search and consider specific causes (tuberculosis, bacterial, autoimmune, malignancy) that may require targeted therapy beyond anti-inflammatory treatment 1.
The evidence strongly supports this dual NSAID-colchicine approach as it addresses both immediate pain relief and prevention of the most common complication (recurrence), which occurs in 15-30% of patients not treated with colchicine 1, 2.